GUILLERMO GARCIA-MANERO to Intercellular Signaling Peptides and Proteins
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Intercellular Signaling Peptides and Proteins.
Connection Strength
0.293
-
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management. Am J Hematol. 2015 Sep; 90(9):831-41.
Score: 0.104
-
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. PLoS One. 2013; 8(4):e61807.
Score: 0.088
-
Standard therapy for patients with myelodysplastic syndromes. Clin Lymphoma Myeloma Leuk. 2011 Aug; 11(4):303-13.
Score: 0.078
-
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases. Cancer. 2003 Apr 15; 97(8):1920-8.
Score: 0.011
-
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2003 Mar 01; 97(5):1234-41.
Score: 0.011